Identification of high-quality cancer prognostic markers and metastasis network modules
about
A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progressionDiagnostic Value of SLC26A4 Mutation Status in Hereditary Hearing Loss With EVA: A PRISMA-Compliant Meta-AnalysisNetwork biomarkers reveal dysfunctional gene regulations during disease progressionFrom modules to medicine: How modular domains and their associated networks can enable personalized medicineIntegrative analysis of cancer imaging readouts by networksStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewCancer subtype discovery and biomarker identification via a new robust network clustering algorithmAn integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathwaysInferring gene dependency network specific to phenotypic alteration based on gene expression data and clinical information of breast cancerA Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies.NAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples.Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.Predicting cancer prognosis using functional genomics data sets.Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network.Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast CancerA New Approach for Identification of Cancer-related Pathways using Protein Networks and Genomic Data.Mining breast cancer genes with a network based noise-tolerant approachBig genomics and clinical data analytics strategies for precision cancer prognosisIdentification of cancer risk lncRNAs and cancer risk pathways regulated by cancer risk lncRNAs based on genome sequencing data in human cancers.Surgical treatment in Paget's disease with invasive ductal carcinoma: an observational study based on SEERSystematic functional perturbations uncover a prognostic genetic network driving human breast cancerNetwork Analysis Reveals A Signaling Regulatory Loop in the PIK3CA-mutated Breast Cancer Predicting Survival Outcome.eTumorType, An Algorithm of Discriminating Cancer Types for Circulating Tumor Cells or Cell-free DNAs in Blood.Inferring probabilistic miRNA-mRNA interaction signatures in cancers: a role-switch approach.Disease biomarker identification from gene network modules for metastasized breast cancerImpact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.Some dietary factors can modulate the effect of the zinc transporters 8 polymorphism on the risk of metabolic syndromePrognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma.Dynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy.Multi-level reproducibility of signature hubs in human interactome for breast cancer metastasis.ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.3'UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network.Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populationsThe CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasmsLarge-scale analysis of expression signatures reveals hidden links among diverse cellular processes.Computational prognostic indicators for breast cancer.Inferring causal genomic alterations in breast cancer using gene expression data.Prioritizing cancer-related genes with aberrant methylation based on a weighted protein-protein interaction network.Long noncoding RNA associated-competing endogenous RNAs in gastric cancerFEN1 -69G>A and 4150G>T polymorphisms and cancer risk in Chinese population.
P2860
Q21202767-33572AD7-C862-4A36-B4EA-80BCC8AA1745Q26774741-58B6C8CB-31BC-459E-809B-FC03C50F807AQ26824601-23A7C598-DD3D-44B8-815A-844C0D182B1EQ26830811-C10073B9-D105-4EFC-BFC7-A73CE491400AQ26999069-C7F7CCC9-EC91-428B-84B6-D842CF499F22Q27008867-63EF8281-1ECA-4E59-87A2-20DD4C837466Q28533973-C3DF73CC-9E80-4313-98E3-C14A47BC333DQ28709213-ED105E98-631F-45C6-93A4-B6D28B3952CFQ30000682-06D10F01-F746-4470-9021-EDE607D700F0Q30250910-8F6E538A-D958-4FAA-BBB8-2DC9632E7CBBQ30366556-9D4D5839-81B9-43C4-8023-FAB7A19121B8Q30847181-52B01D57-D700-423F-A180-85D35F4D77D3Q30869262-C5322F98-8990-4E06-9590-DCA0AD9188A0Q31014656-39C8AAE8-46AB-45CF-BE61-7F8FFA3B0C56Q31015478-A252C8BE-689A-4A8C-944B-CBA55C1CEC76Q31093592-EF466999-1643-4EBF-83BE-D44939C228AAQ31121954-1CD942ED-B8EA-4CBD-A079-F076A219B030Q31141213-D8ABAE78-674D-4494-A11C-5C539F9552A7Q31149938-7F128D76-17A0-4201-9D0F-AE45E6A25BD7Q33576582-08AC1DF6-23AD-4072-8D82-046F6912A290Q33591245-70D2FBF2-CDC6-4303-8143-ABFEF864838CQ33631628-AFA66FA2-DCC6-4D33-A527-FC5B002B6AC0Q33631634-90033D1B-424D-445B-B13D-6633E1E00C8AQ33635579-9592F5F4-ADD3-4842-827D-744D26BCF536Q33682231-4E8BFB69-5AC9-4584-B03F-96071904788CQ33683344-A72C167E-B2C7-48A0-AD3D-0A4F76DBA5A4Q33687695-1050A2DC-B21A-4D05-BFF0-DAD0FA00B513Q33700571-A30C8048-F3BA-42D2-938F-24145FF5F5BBQ33719832-3C1E907F-501A-46D9-A47F-BC14D307F83FQ33741210-2B69055E-C867-413E-A645-E872B6A4979EQ33779292-C63F5D0F-C754-42BD-9E9F-068177B2E994Q33788981-24ED2EFB-61BF-467E-B595-E27A0B064333Q33870813-B742919D-6B02-48FD-BA44-E0CD636133CDQ33905783-5776324E-444F-400B-A058-833A2BA2D3D7Q33914495-AAC56D84-54CE-4770-ADC5-4302AE4DD110Q33921791-53EE83D2-E9FC-4C51-B95C-62F4DA66E4D7Q33977659-6A787AE3-12F6-42B8-A871-B5E0C5A73C1FQ34045429-CE196D28-2759-435D-9045-D09F0884B915Q34048763-DBDDDE03-6D9E-4E78-B0A5-821753B98825Q34085818-82F1F178-B386-4A40-BD26-A29523D2E207
P2860
Identification of high-quality cancer prognostic markers and metastasis network modules
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of high-quality cancer prognostic markers and metastasis network modules
@ast
Identification of high-quality cancer prognostic markers and metastasis network modules
@en
Identification of high-quality cancer prognostic markers and metastasis network modules
@nl
type
label
Identification of high-quality cancer prognostic markers and metastasis network modules
@ast
Identification of high-quality cancer prognostic markers and metastasis network modules
@en
Identification of high-quality cancer prognostic markers and metastasis network modules
@nl
prefLabel
Identification of high-quality cancer prognostic markers and metastasis network modules
@ast
Identification of high-quality cancer prognostic markers and metastasis network modules
@en
Identification of high-quality cancer prognostic markers and metastasis network modules
@nl
P2093
P2860
P356
P1476
Identification of high-quality cancer prognostic markers and metastasis network modules
@en
P2093
Anne E G Lenferink
Catherine Collins
Edwin Wang
Enrico O Purisima
Maureen D O'Connor-McCourt
Qinghua Cui
Yinghai Deng
P2507
P2860
P2888
P356
10.1038/NCOMMS1033
P407
P577
2010-07-13T00:00:00Z
P5875
P6179
1038660365